Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-28 @ 12:10 AM
Study NCT ID:
NCT01291394
Status:
COMPLETED
Last Update Posted:
2017-12-26
First Post:
2011-01-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-31
First Submit QC Date:
None
Study First Post Date:
2011-02-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-22
Last Update Post Date:
2017-12-26
Last Update Post Date Type:
ACTUAL